Cumberland Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Cumberland Pharmaceuticals has a total shareholder equity of $27.2M and total debt of $16.1M, which brings its debt-to-equity ratio to 59.2%. Its total assets and total liabilities are $81.5M and $54.3M respectively.
Key information
59.2%
Debt to equity ratio
US$16.08m
Debt
| Interest coverage ratio | n/a |
| Cash | US$18.55m |
| Equity | US$27.19m |
| Total liabilities | US$54.32m |
| Total assets | US$81.51m |
Recent financial health updates
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Mar 07
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Aug 10Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet?
Mar 18Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Nov 02Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Apr 15Health Check: How Prudently Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Use Debt?
Nov 09Recent updates
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Mar 07Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Prospects Need A Boost To Lift Shares
Jan 09Why Investors Shouldn't Be Surprised By Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S
Oct 02Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Aug 10Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet?
Mar 18Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Nov 02Calculating The Fair Value Of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
Jul 20Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Apr 15Checking In On Cumberland Pharmaceuticals
Jan 04Health Check: How Prudently Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Use Debt?
Nov 09We Think Some Shareholders May Hesitate To Increase Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) CEO Compensation
Apr 21Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Debt In A Risky Way?
Feb 13One Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Analyst Just Cut Their EPS Forecasts
Nov 19
Cumberland Pharmaceuticals Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 11Financial Position Analysis
Short Term Liabilities: CPIX's short term assets ($36.2M) exceed its short term liabilities ($26.4M).
Long Term Liabilities: CPIX's short term assets ($36.2M) exceed its long term liabilities ($27.9M).
Debt to Equity History and Analysis
Debt Level: CPIX has more cash than its total debt.
Reducing Debt: CPIX's debt to equity ratio has increased from 36.2% to 59.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CPIX has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CPIX is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 37.7% per year.